trimethoprim has been researched along with Carcinoma, Transitional Cell in 1 studies
Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.
Carcinoma, Transitional Cell: A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeuchi, H | 1 |
| Ozasa, Y | 1 |
| Sasaki, S | 1 |
| Oshima, M | 1 |
1 other study available for trimethoprim and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
[A case of pneumocystis carinii pneumonia after chemotherapy of bladder tumor].
Topics: Aged; Carcinoma, Transitional Cell; Doxorubicin; Drug Combinations; Humans; Male; Pneumonia, Pneumoc | 1985 |